Cosmos Health (NASDAQ:COSM) Stock Crosses Above 50 Day Moving Average – Time to Sell?

Posted by Brenda Bartman on Oct 31st, 2026

Cosmos Health Inc. (NASDAQ:COSM – Get Free Report) shares crossed above its 50-day moving average during trading on Friday. The stock has a 50-day moving average of $0.30 and traded as high as $0.31. Cosmos Health shares last traded at $0.3079, with a volume of 2,068,763 shares changing hands.

Analysts Set New Price Targets

A number of analysts have recently weighed in on COSM shares. Weiss Ratings reissued a “sell (d-)” rating on shares of Cosmos Health in a research report on Wednesday. Noble Financial assumed coverage on Cosmos Health in a research report on Monday. They set an “outperform” rating on the stock. One equities research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Hold”.

Read Our Latest Research Report on COSM

Cosmos Health Price Performance

The stock has a market cap of $30.98 million, a price-to-earnings ratio of -0.48 and a beta of 4.69. The stock’s 50 day moving average price is $0.30 and its two-hundred day moving average price is $0.31. The company has a quick ratio of 0.92, a current ratio of 1.05 and a debt-to-equity ratio of 0.15.

Cosmos Health (NASDAQ:COSM – Get Free Report) last issued its earnings results on Tuesday, August 18th. The company reported ($0.10) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.10). The firm had revenue of $19.32 million during the quarter, compared to analysts’ expectations of $18.99 million. Cosmos Health had a negative net margin of 33.08% and a negative return on equity of 56.88%. Equities research analysts forecast that Cosmos Health Inc. will post -0.15 EPS for the current fiscal year.

Hedge Funds Weigh In On Cosmos Health

An institutional investor recently raised its stake in Cosmos Health stock. Renaissance Technologies LLC boosted its stake in shares of Cosmos Health Inc. (NASDAQ:COSM – Free Report) by 16.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 390,500 shares of the company’s stock after acquiring an additional 55,925 shares during the quarter. Renaissance Technologies LLC owned 0.75% of Cosmos Health worth $124,000 at the end of the most recent reporting period. 12.61% of the stock is currently owned by institutional investors.

Cosmos Health Company Profile

(Get Free Report)

Cosmos Health Inc is a healthcare group that develops, manufactures and distributes pharmaceutical, nutraceutical and healthcare products. Its portfolio includes branded dietary supplements, vitamins and wellness products, as well as pharmaceutical products and medical devices distributed through retail, wholesale and online channels.

The company markets its nutraceutical products under the Sky Premium Life brand, which offers supplements and other health and wellness products. Cosmos Health also has manufacturing and product-development activities through Cana Laboratories, a Greece-based pharmaceutical manufacturer that produces pharmaceutical and healthcare products for its own portfolio and third parties.

Founded in 2009 and formerly known as Cosmos Holdings, the company adopted the Cosmos Health name in 2022.